Article Details
Retrieved on: 2024-06-02 17:38:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
First, the desire for more individualized and targeted therapy alternatives, such as monoclonal antibodies or TROP2 inhibitors, is driven by the ...
Article found on: www.whatech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here